Trial Profile
A randomized, double-blinded, active-controlled multicenter clinical trial to evaluate prophylactic anti-emetic efficacy of ramosetron and ondansetron on post-operative nausea and vomiting in patients with intravenous patient-controlled analgesia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary) ; Ondansetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- Acronyms PONV ramosetron
- 16 Feb 2017 New trial record